NLRP3 inflammasome inhibition with MCC950 improves insulin sensitivity and inflammation in a mouse model of frontotemporal dementia

Hull, Claire; Dekeryte, Ruta; Buchanan, Heather; Kamli-Salino, Sarah; Robertson, Avril; Delibegovic, Mirela; Platt, Bettina

NLRP3 inflammasome inhibition with MCC950 improves insulin sensitivity and inflammation in a mouse model of frontotemporal dementia

Files

Hull_et_al_NePh_NLRPInflammasomeInhibition_AAM.pdf (3.65 MB)

Date

2020-12-01

Authors

Citation

Hull, C, Dekeryte, R, Buchanan, H, Kamli-Salino, S, Robertson, A, Delibegovic, M & Platt, B 2020, 'NLRP3 inflammasome inhibition with MCC950 improves insulin sensitivity and inflammation in a mouse model of frontotemporal dementia', Neuropharmacology, vol. 180, 108305. https://doi.org/10.1016/j.neuropharm.2020.108305, https://doi.org/10.1016/j.neuropharm.2020.108305